TLRY

TLRY

USD

Tilray Brands Inc. Common Stock

$1.242+0.002 (0.194%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.240

High

$1.280

Low

$1.210

Volume

36.04M

Company Fundamentals

Market Cap

1.4B

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

Trading Stats

Avg Volume

83.45M

Exchange

NMS

Currency

USD

52-Week Range

Low $0.35Current $1.242High $2.32

Related News

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

View more
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
GlobeNewswire

Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan's Premier American Craft Beer Experience Festival

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is

View more
Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan's Premier American Craft Beer Experience Festival
GlobeNewswire

Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work

SEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Redhook Brewing, creator of the hardest working beer in the fridge and a craft brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged

View more
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
GlobeNewswire

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between

View more
Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth